Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT04231708
PHASE2

Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder

Sponsor: Wayne State University

View on ClinicalTrials.gov

Summary

This preliminary study is designed to evaluate mechanisms by which excitatory dorsolateral prefrontal cortex (dlPFC) repetitive transcranial magnetic stimulation (rTMS) (vs. sham) and pharmacological stress (vs. placebo) alter behavior in non-treatment seeking individuals with opioid use disorder (OUD). Specific Aims are to (1) Evaluate how stress impacts domains of behavior including (1a) executive function and (1b) opioid-seeking behavior; and (2) Determine whether rTMS stimulation attenuates (2a) executive dysfunction, (2b) stress-reactivity, and (2c) opioid-seeking in individuals with OUD not receiving treatment.

Official title: Effects of Pharmacological Stress and Repetitive Transcranial Magnetic Stimulation Interventions on Executive Function in Opioid Use Disorder

Key Details

Gender

All

Age Range

21 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-10

Completion Date

2028-12

Last Updated

2025-12-30

Healthy Volunteers

No

Interventions

DRUG

Yohimbine + Hydrocortisone

Yohimbine (54mg bulk powder inside capsule) administered in combination with Hydrocortisone (20mg tablet inside capsule)

DEVICE

Active rTMS

10Hz rTMS over the left dlPFC

DRUG

Placebo

lactose (inside capsule)

DEVICE

Sham rTMS

inactive stimulation over the left dlPFC

Locations (1)

Tolan Park Medical Building

Detroit, Michigan, United States